The Largest Personal Injury Firm in Texas. Serving Clients Nationwide.
Corpus Christi 361-985-0600 San Antonio 210-656-1000 Nationwide Toll Free 888-314-9945
Contact us 24/7

Johnson and Johnson Under Scrutiny by DHH for Nucynta

View all
Jarod Cassidy4 years ago

According to the Wall Street Journal, Johnson and Johnson has received a subpoena from the Department of Health and Human Services (HHS) requesting documents and information concerning their opioid painkiller, Nucynta.

The subpoena comes after increased reports of painkiller abuse and overdose.

Johnson & Johnson and Nucynta Subpoena

  • Nucynta comes in two forms: an immediate release tablet and an extended release tablet.
  • The immediate release form of Nucynta was approved by the FDA in 2008. The extended release version was approved in 2011.
  • The subpoena is seeking any studies, reports and complaints regarding the study of the tablets on the subject of actual or potential side effects.
  • This includes company documents and information on promotional practices, marketing and sales of both forms of Nucynta.
  • The subpoena came from the HHS Office of Inspector General – a department that normally focuses on allegations of fraud and abuse in federal health programs.

Side Effects and Adverse Events Related to Nucynta

For complete list, click here.

  • Seizure
  • Hallucination
  • Weak Pulse
  • Weak Breathing
  • Slow Heartbeat
  • Respiratory Depression

Of 1,156 adverse events reported through the FDA, 67 (5.8%) resulted in death. Reports of deaths peaked in late 2011 after the launch of Nucynta’s extended release tablet.

Current Precautions Taken with Nucynta

Currently, extended release Nucynta carries a prescribing label that warns about respiratory depression and a potential for abuse.

Doctors must undergo training on how to prescribe the correct amount of extended release Nucynta to avoid over-prescription of the drug.

Contact an Experienced Product Liability Attorney

Thomas J. Henry are leaders in the area of drug and product liability litigation. Our Defective Drug and Products Division have extensive knowledge and resources in order to represent our clients efficiently and aggressively. The Defective Drug and Products Division represent a multitude of people who are battling against manufacturers of medical devices and/ or defective pharmaceuticals.

If you or a loved one have been injured by or have developed serious side-effects from the use of defective medications or pharmaceuticals, contact Thomas J. Henry immediately. We represent clients/victims all over the country. We are available 24/7, nights and weekends.


Contact Us for a FREE Case Review

888-314-9945 •